Coverage for Routine Childhood Vaccines Remains Below Prepandemic Levels
WEDNESDAY, March 26, 2025 -- Three years after the start of the COVID-19 pandemic, coverage for selected routine childhood vaccines remained below prepandemic levels, according to a study published online March 26 in Pediatrics.
Malini B. DeSilva, M.D., from HealthPartners Institute in Bloomington, Minnesota, and colleagues examined rotavirus; diphtheria, tetanus, and acellular pertussis; and pneumococcal conjugate vaccine coverage among infants born between Jan. 1, 2018, and May 31, 2023, and assessed factors associated with vaccine uptake. Data were included for 395,143 infants.
The researchers found that at 5 months of age, coverage for two doses of all three vaccines was 87.8 and 80.8 percent in February 2020 and October 2023, respectively. At 12 months, vaccine series completion was highest in January 2020 and lower in October 2023 (92.3 and 89.6 percent, respectively). Having a caregiver whose primary language was not English or Spanish, non-Hispanic Black race, and Medicaid were factors associated with lower vaccine uptake.
"Three years after the start of the COVID-19 pandemic, coverage for selected routine childhood immunizations remained below prepandemic levels," the authors write. "Although our findings highlight population groups for whom focused interventions are needed to improve vaccine coverage, further understanding of how these factors may be related to other sociodemographic and cultural factors, availability of care, structural barriers to accessing care, and vaccine confidence, is needed."
Several authors disclosed financial ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Further Support and Information on COVID-19
Read this next
Higher Tattoo Exposure Linked to Reduced Melanoma Risk
MONDAY, Sept. 29, 2025 -- Higher tattoo exposure may be associated with reduced melanoma risk, according to a study published online Aug. 21 in the Journal of the National Cancer...
Antithymocyte Globulin Cuts Loss of β-Cell Function in Type 1 Diabetes
MONDAY, Sept. 29, 2025 -- Antithymocyte globulin (ATG) 2.5 and 0.5 mg/kg reduces loss of β-cell function in young people with recent-onset type 1 diabetes, according to a...
Loss of Therapeutic Benefit Seen After Stopping Baricitinib in Type 1 Diabetes
MONDAY, Sept. 29, 2025 -- Two-year follow-up shows a loss of therapeutic benefit when baricitinib treatment is stopped in type 1 diabetes (T1D), according to a study presented at...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.